PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.18%
Growth of 2.18% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
19.31%
Cost growth of 19.31% versus flat Healthcare costs. Walter Schloss would verify cost control.
-22.45%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-24.11%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-21.64%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-4.92%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
26.68%
Marketing expense change of 26.68% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-196.11%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
1.34%
Operating expenses growth below 50% of Healthcare median of 9.47%. Joel Greenblatt would investigate efficiency.
12.78%
Total costs growth 1.25-1.5x Healthcare median of 9.61%. Guy Spier would scrutinize spending.
-3.55%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-59.60%
D&A reduction while Healthcare median is 1.07%. Seth Klarman would investigate efficiency.
-345.70%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
23.03%
Margin change of 23.03% versus flat Healthcare. Walter Schloss would verify quality.
-866.94%
Operating income decline while Healthcare median is -1.45%. Seth Klarman would investigate causes.
-850.60%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-248.96%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-969.84%
Pre-tax income decline while Healthcare median is -0.55%. Seth Klarman would investigate causes.
-951.31%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-137.19%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-1775.75%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1740.06%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1785.39%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1785.39%
Diluted EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
11.26%
Share count change of 11.26% versus stable Healthcare. Walter Schloss would verify approach.
11.07%
Diluted share change of 11.07% versus stable Healthcare. Walter Schloss would verify approach.